We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EverQuote, Inc. (EVER - Free Report) reported adjusted net loss of 12 cents per share for third-quarter 2020, wider than the Zacks Consensus Estimate of a loss of 5 cents per share. In the year-ago quarter, operating income was 1 cent per share.
EverQuote witnessed increased revenues from automotive insurance and other insurance verticals in the reported quarter, offset by higher expenses.
Total revenues improved 34.1% year over year to $89.9 million, driven by the solid performance of automotive insurance vertical and other verticals. Moreover, the top line beat the Zacks Consensus Estimate by 5.8%.
Variable marketing margin grew 41% year over year to $29.4 million.
Revenues from automotive insurance vertical increased 30% year over year to $74.8 million.
Revenues from other insurance verticals, which include home and renters, life, health and commercial insurance, increased 55% from the year-ago period to $15.2 million.
Total costs and operating expenses increased 38.8% to $93.3 million mainly due to higher cost of revenues, sales and marketing, research and development, and general and administrative expenses.
Adjusted EBITDA increased 34.9% year over year to $5.2 million.
Financial Update
As of Sep 30, 2020, EverQuote had assets worth $116.2 million, up 27.4% from the level at 2019 end.
Cash and cash equivalents declined 0.4% from the 2019-end level to $45.9 million.
Shareholder equity at the end of the reported quarter increased 29.8% from the 2019-end to $67.2 million.
EverQuote’s cash flow from operations increased 39.4% year over year to $6 million.
Q4 Guidance
Revenues are anticipated to be $90.4-$92.4 million.
Variable marketing margin is projected to be $29.3-$30.3 million.
Adjusted EBITDA is expected to be $4-$5 million.
2020 Guidance
Revenues are anticipated to be in the range of $340-$342 million, up from the previously mentioned $331-$336 million.
Variable marketing margin is projected to be $106-$107 million, up from the previously guided range of $101-$104.5 million.
Adjusted EBITDA is expected to be $17-$18 million, higher than $15-$17.5 million guided previously.
Zacks Rank
EverQuote currently carries a Zacks Rank #4 (Sell).
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
EverQuote (EVER) Reports Wider Q3 Loss, Raises 2020 Guidance
EverQuote, Inc. (EVER - Free Report) reported adjusted net loss of 12 cents per share for third-quarter 2020, wider than the Zacks Consensus Estimate of a loss of 5 cents per share. In the year-ago quarter, operating income was 1 cent per share.
EverQuote witnessed increased revenues from automotive insurance and other insurance verticals in the reported quarter, offset by higher expenses.
EverQuote, Inc. Price, Consensus and EPS Surprise
EverQuote, Inc. price-consensus-eps-surprise-chart | EverQuote, Inc. Quote
Behind the Headlines
Total revenues improved 34.1% year over year to $89.9 million, driven by the solid performance of automotive insurance vertical and other verticals.
Moreover, the top line beat the Zacks Consensus Estimate by 5.8%.
Variable marketing margin grew 41% year over year to $29.4 million.
Revenues from automotive insurance vertical increased 30% year over year to $74.8 million.
Revenues from other insurance verticals, which include home and renters, life, health and commercial insurance, increased 55% from the year-ago period to $15.2 million.
Total costs and operating expenses increased 38.8% to $93.3 million mainly due to higher cost of revenues, sales and marketing, research and development, and general and administrative expenses.
Adjusted EBITDA increased 34.9% year over year to $5.2 million.
Financial Update
As of Sep 30, 2020, EverQuote had assets worth $116.2 million, up 27.4% from the level at 2019 end.
Cash and cash equivalents declined 0.4% from the 2019-end level to $45.9 million.
Shareholder equity at the end of the reported quarter increased 29.8% from the 2019-end to $67.2 million.
EverQuote’s cash flow from operations increased 39.4% year over year to $6 million.
Q4 Guidance
Revenues are anticipated to be $90.4-$92.4 million.
Variable marketing margin is projected to be $29.3-$30.3 million.
Adjusted EBITDA is expected to be $4-$5 million.
2020 Guidance
Revenues are anticipated to be in the range of $340-$342 million, up from the previously mentioned $331-$336 million.
Variable marketing margin is projected to be $106-$107 million, up from the previously guided range of $101-$104.5 million.
Adjusted EBITDA is expected to be $17-$18 million, higher than $15-$17.5 million guided previously.
Zacks Rank
EverQuote currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1Rank (Strong Buy) stocks here.
Performance of Other Insurers
Third-quarter earnings of CNA Financial (CNA - Free Report) , Assurant (AIZ - Free Report) , Markel (MKL - Free Report) beat the respective Zacks Consensus Estimate.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>